company background image
HMD logo

HeraMED ASX:HMD Stock Report

Last Price

AU$0.021

Market Cap

AU$13.3m

7D

-4.5%

1Y

-61.8%

Updated

08 Nov, 2024

Data

Company Financials

HMD Stock Overview

Develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel.

HMD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

HeraMED Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HeraMED
Historical stock prices
Current Share PriceAU$0.021
52 Week HighAU$0.055
52 Week LowAU$0.012
Beta0.084
11 Month Change0%
3 Month Change50.00%
1 Year Change-61.82%
33 Year Change-92.08%
5 Year Change-90.23%
Change since IPO-88.33%

Recent News & Updates

Recent updates

Shareholder Returns

HMDAU Medical EquipmentAU Market
7D-4.5%2.0%0.7%
1Y-61.8%13.8%16.7%

Return vs Industry: HMD underperformed the Australian Medical Equipment industry which returned 13.8% over the past year.

Return vs Market: HMD underperformed the Australian Market which returned 16.7% over the past year.

Price Volatility

Is HMD's price volatile compared to industry and market?
HMD volatility
HMD Average Weekly Movement18.1%
Medical Equipment Industry Average Movement9.8%
Market Average Movement8.5%
10% most volatile stocks in AU Market17.2%
10% least volatile stocks in AU Market3.5%

Stable Share Price: HMD's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: HMD's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2011n/aAnoushka Gungadinwww.hera-med.com

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus’ heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform.

HeraMED Limited Fundamentals Summary

How do HeraMED's earnings and revenue compare to its market cap?
HMD fundamental statistics
Market capAU$13.30m
Earnings (TTM)-AU$6.73m
Revenue (TTM)AU$486.98k

27.3x

P/S Ratio

-2.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HMD income statement (TTM)
RevenueAU$486.98k
Cost of RevenueAU$268.47k
Gross ProfitAU$218.51k
Other ExpensesAU$6.94m
Earnings-AU$6.73m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.011
Gross Margin44.87%
Net Profit Margin-1,381.03%
Debt/Equity Ratio16.4%

How did HMD perform over the long term?

See historical performance and comparison